| Page 2076 | Kisaco Research
 

Simon Blackmore

Professor
Harper Adams University

Simon Blackmore is a key figure in the development of Precision Farming and agricultural robotics, with a world-wide reputation. Simon is currently Professor and Head of Robotics and Automation, Agri-Epi Centre at Harper Adams University, Director of the National Centre for Precision Farming and managed the European FutureFarm project.

Simon has extensive experience of multidisciplinary collaboration across universities, commercial partnerships and research projects including autonomous tractors, laser weeding, robotic phenotyping and robotic harvesting.

Simon Blackmore

Professor
Harper Adams University

Simon Blackmore

Professor
Harper Adams University

Simon Blackmore is a key figure in the development of Precision Farming and agricultural robotics, with a world-wide reputation. Simon is currently Professor and Head of Robotics and Automation, Agri-Epi Centre at Harper Adams University, Director of the National Centre for Precision Farming and managed the European FutureFarm project.

Simon has extensive experience of multidisciplinary collaboration across universities, commercial partnerships and research projects including autonomous tractors, laser weeding, robotic phenotyping and robotic harvesting.

Simon holds seven Chairs around the world and gives many national and international keynote presentations. Simon leads the research in the UK on agricultural robotics.

Simon personal research focuses on improving Precision Farming by developing more intelligent machines and processes, and making crop production more efficient and sustainable.

 

Dr. Huub Schepers

Wageningen University

Dr. Huub Schepers

Wageningen University

Dr. Huub Schepers

Wageningen University
 

Dr. Fideline Tchuenbou-Magaia

University of Wolverhampton

Dr Fideline Tchuenbou-Magaia is a senior lecturer at the University of Wolverhampton, UK. She has more than 10 year experience in formulation engineering with focus on encapsulation and controlled release of molecules. Dr Tchuenbou-Magaia has developed controlled release formulations with application primarily in food and nutraceuticals, oral healthcare and cosmetics, agrochemical, energy storage and carbon capture.

Dr. Fideline Tchuenbou-Magaia

University of Wolverhampton

Dr. Fideline Tchuenbou-Magaia

University of Wolverhampton

Dr Fideline Tchuenbou-Magaia is a senior lecturer at the University of Wolverhampton, UK. She has more than 10 year experience in formulation engineering with focus on encapsulation and controlled release of molecules. Dr Tchuenbou-Magaia has developed controlled release formulations with application primarily in food and nutraceuticals, oral healthcare and cosmetics, agrochemical, energy storage and carbon capture. Further information about Dr Tchuenbou-Magaia can be found on the University of Wolverhampton website, https://www.wlv.ac.uk/about-us/our-schools-and-institutes/faculty-of-science-and-engineering/all-faculty-staff/school-of-engineering-staff/dr-fideline-laure-tchuenbou-magaia/

 

Ketan Mehta

CEO
Ecosense, India

Ketan Mehta

CEO
Ecosense, India

Ketan Mehta

CEO
Ecosense, India
 

Dr. Anant Patel

Bielefeld University of Applied Sciences Germany

Dr. Anant Patel

Bielefeld University of Applied Sciences Germany

Dr. Anant Patel

Bielefeld University of Applied Sciences Germany
 
Health, Wellness & Money
21 Nov 2017
London, UK
Health, Wellness & Money is THE destination for the hottest early to mid-stage OTC health and wellness companies and healthtech innovators to connect with Strategic and Financial Buyers looking to build even more enterprise value with their next acquisition or investment.Every attendee, via the MEETING MOJO platform, will be able to schedule 12+ One-to-One private meetings to ensure the right connections are made.Why Consumer Health & Wellness? $3.4 TRILLION GLOBAL WELLNESS MARKET IS NOW THREE TIMES LARGER THAN WORLDWIDE PHARMACEUTICAL INDUSTRY. Global Wellness Institute StudyWellness sectors seeing the most significant growth since 2010 are:Healthy eating, nutrition and weight loss (108 percent increase to $276.5 billion)Preventative and personalized health (78 percent increase to $243 billion)Complementary and alternative medicine (65 percent increase to $113 billion)
 

Terri Goldstein

Founder & CEO
The Goldstein Group

Terri Goldstein is the Founder & CEO of The Goldstein Group. During her 25-year career, executives in the CPG and Pharmaceutical industries have turned to Terri for her expertise in brand identity and design. Terri has strengthened the brand identity and business health of over 400 global and domestic consumer products and services developing iconic brand identities that truly endure the test of time. 
 

Terri Goldstein

Founder & CEO
The Goldstein Group

Terri Goldstein

Founder & CEO
The Goldstein Group

Terri Goldstein is the Founder & CEO of The Goldstein Group. During her 25-year career, executives in the CPG and Pharmaceutical industries have turned to Terri for her expertise in brand identity and design. Terri has strengthened the brand identity and business health of over 400 global and domestic consumer products and services developing iconic brand identities that truly endure the test of time. 
 
Terri has been profiled in Advertising Age (Packaging Guru Proves What’s On Outside Counts – And Sells) and was named a GDUSA Person to Watch. She is a keynote speaker at PIMS, The Marketing Institute, CHPA and many industry conferences. She serves as a guest lecturer at FIT, regularly contributes to Adweek, Brand Packaging and Graphic Design USA, and is the author of breakthrough research on consumer behavior, recall, and sensory motivation in the retail environment. 

 

Ed Rowland

Founder and Managing Partner
Rowland Global

Ed Rowland

Founder and Managing Partner
Rowland Global

Ed Rowland

Founder and Managing Partner
Rowland Global
 

Seb Mullin

Managing Director
Rude Health

Seb Mullin

Managing Director
Rude Health

Seb Mullin

Managing Director
Rude Health
 

Coulton Legge

Director Global Open Innovation
Bayer Consumer HealthCare

19+ years in Healthcare – Pharmaceutical and Consumer (OTC / FMCG) 

Physicist driven by innovation to generate commercial value (backed by intellectual property where possible), using consumer insights for new product development and investigating new technologies for unmet consumer health needs.

Current Categories of interest:
Analgesics, Allergy, Cough and Cold, Dermatology, GI, Nutritionals, Sun Care and Foot Care 

Experience in building teams with multidisciplinary skills, both in UK and US and working with 3rd parties.

Coulton Legge

Director Global Open Innovation
Bayer Consumer HealthCare

Coulton Legge

Director Global Open Innovation
Bayer Consumer HealthCare

19+ years in Healthcare – Pharmaceutical and Consumer (OTC / FMCG) 

Physicist driven by innovation to generate commercial value (backed by intellectual property where possible), using consumer insights for new product development and investigating new technologies for unmet consumer health needs.

Current Categories of interest:
Analgesics, Allergy, Cough and Cold, Dermatology, GI, Nutritionals, Sun Care and Foot Care 

Experience in building teams with multidisciplinary skills, both in UK and US and working with 3rd parties.